This survey report explores how biopharma leaders see third party logistics partners as part of the solution.
The landscape surrounding pharma commercialization is getting more complex by the day. With shifting regulatory dynamics, cell and gene momentum, and supply chain volatility, manufacturers are approaching their logistics planning to address these evolving demands. Factors like cold-chain storage and advanced serialization are taking top priority – and industry leaders are focused on how third-party logistics (3PL) partners can offer solutions.
How is your pharma manufacturing planning to become more resilient as the market, science, and policies become more complex?
Download the survey report to find out how biopharma leaders increasingly see 3PL partners as part of the solution. Findings include:
Offered Free by: BioPharma Dive's studioID and Cardinal Health
See All Resources from: BioPharma Dive's studioID and Cardinal Health